Options for immunologic support of renal transplantation through the HLA and immunology laboratories

American Journal of Transplantation

Volumn 7, Issue 6, 2007, Pages 1450-1456

  Susal C ^a   Opelz, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Graft rejection; HLA; Laboratory testing; Non HLA; Transplant immunology

Indexed keywords

CD30 ANTIGEN; CYTOKINE; HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; RNA;

ANTIBODY BLOOD LEVEL; BLOOD TRANSFUSION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOMICS; HLA MATCHING; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOGENETICS; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SERODIAGNOSIS; SHORT SURVEY;

GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 34248654565     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01824.x     Document Type: Short Survey

References (39)

1. Mange KC, Cherikh WS, Maghirang J, Bloom RD. A comparison of the survival of shipped and locally transplanted cadaveric renal allografts. N Engl J Med 2001 345 : 1237 1242.
2. Opelz G, Döhler B. Multicenter analysis of kidney preservation. Transplantation 2007 83 : 247 253.
3. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999 1 : 334 342.
4. Süsal C, Pelzl S, Opelz G. Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 2003 76 : 1231 1232.
5. Mizutani K, Terasaki P, Rosen A et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005 5 : 2265 2272.
6. Tran TH, Mytilineos J, Scherer S, Laux G, Middleton D, Opelz G. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005 80 : 1121 1123.
7. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 2001 71 : 674 677.
8. Mytilineos J, Laux G, Opelz G. Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: A collaborative transplant study report. Am J Transplant 2004 4 : 1684 1690.
9. Opelz G, Graver B, Mickey MR, Terasaki PI. Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 1981 32 : 177 183.
10. Christiaans MH, Nieman F, van Hooff JP, Van Den Berg-Loonen EM. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000 69 : 917 927.
11. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006 82 : 1524 1528.
12. Wahrmann M, Exner M, Schillinger M et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006 6 : 1033 1041.
13. Watanabe J, Scornik JC. IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity. Am J Transplant 2005 5 : 2786 2790.
14. Ishida H, Tanabe K, Furusawa M et al. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation. Transpl Int 2005 18 : 163 168.
15. Opelz G Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005 365 : 1570 1576.
16. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000 61 : 917 924.
17. Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002 74 : 268 277.
18. Zou Y, Heinemann FM, Grosse-Wilde H et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 2006 67 : 230 237.
19. Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 2005 80 : 1194 1197.
20. Roussey-Kesler G, Giral M, Moreau A et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006 6 : 736 746.
21. Süsal C, Pelzl S, Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002 13 : 1650 1656.
22. Lazarus AH, Crow AR, Freedman J, Blanchette V, Hannach B. Inhibition of a secondary human alloimmune response via the soluble active component of CD154 in severe combined immune-deficient mice engrafted with human lymphocytes. Transfusion 1999 39 : 818 823.
23. Süsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002 73 : 1269 1273.
24. Mahoney RJ, Taranto S, Edwards E. B-cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients. Hum Immunol 2002 63 : 324 335.
25. Le Bas-Bernardet S, Hourmant M, Valentin N et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003 75 : 477 482.
26. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk. Am J Transplant. 2003 3 : 1488 1500.
27. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999 163 : 2267 2275.
28. Andree H, Nickel P, Nasiadko C et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006 17 : 573 580.
29. Chan KW, Hopke CD, Krams SM, Martinez OM. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses. J Immunol 2002 169 : 1784 1791.
30. Dai Z, Li Q, Wang Y et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004 113 : 310 317.
31. Vaidya S, Partlow D, Barnes T, Gugliuzza K. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies. Transplantation 2006 82 : 1606 1609.
32. Kowalski RJ, Post DR, Mannon RB et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006 82 : 663 668.
33. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998 66 : 562 566.
34. Simon T, Opelz G, Wiesel M, Ott RC, Süsal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003 3 : 1121 1127.
35. Giese T, Zeier M, Schemmer P et al. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: A novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation 2004 77 : 339 344.
36. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005 353 : 2342 2351.
37. Morton AL, Bell EB, Bolton EM et al. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: A role for alloantibody. Eur J Immunol 1993 23 : 2078 2084.
38. Schaub S, Rush D, Wilkins J et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004 15 : 219 227.
39. El Essawy B, Otu HH, Choy B, Zheng XX, Libermann TA, Strom TB. Proteomic analysis of the allograft response. Transplantation 2006 82 : 267 274.